Prot # CSOM230B2406: An Open Label, Multi-centered, Expanded Access Study of Pasireotide S.C. in Patients with Cushing's Disease(Seascape)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/27/12 → 12/31/13

Funding

  • Novartis Pharmaceuticals Corporation (CSOM230B2406)